e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can epidemiological studies determine the productivity-related burden of COPD?
Sanja Stanojevic
Source:
Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sanja Stanojevic. Can epidemiological studies determine the productivity-related burden of COPD?. Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
How to define asthma in large-scale studies?
Source: International Congress 2014 – Is asthma prevalence still increasing?
Year: 2014
Validity and interpretation of mortality, health service and survey data on COPD and asthma in England
Source: Eur Respir J 2003; 21: 279-286
Year: 2003
The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020
Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
External validation of exacerbation and mortality outcomes of health economic decision models for COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
An international investigation into the health status of COPD sufferers
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in patients with difficult asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 536s
Year: 2003
Epidemiological study to assess the quality of life and health care resource utilization by patients with mild COPD (EPIDEPOC)
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
COPD and activities of the daily life: impact of the disease severity results of an epidemiological study
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
COPD heterogeneity: An epidemiological perspective from the PLATINO study
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011
The impact of a definition when assessing the cumulative incidence of exacerbation for a primary care cohort of COPD patient
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Measuring the impact of COPD on patients‘ lives in an international study
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005
Does systematic assessment improve healthcare outcomes and healthcare utilisation in patients with severe asthma?
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011
Health care claims analysis to quantify the burden of moderate-to-severe asthma
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
The paradox of primary care and respiratory health: evidence of benefit for people and populations with asthma and COPD
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept